Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary chronic pancreatitis.

Jonas Rosendahl1, Hans Bödeker, Joachim Mössner

  • 1Medizinische Klinik und Poliklinik II, Universität Leipzig, Germany. jonas.rosendahl@medizin.uni-leipzig.de

Orphanet Journal of Rare Diseases
|January 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease.

Therapeutic advances in gastroenterology·2026
Same author

Therapy Persistence and Dose Escalation of Advanced Treatments in First and Second Line of Ulcerative Colitis and Crohn's Disease - A Retrospective Cohort Analysis of Healthcare Claims Data.

Zeitschrift fur Gastroenterologie·2026
Same author

International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG.

United European gastroenterology journal·2026
Same author

Real-world Effectiveness of Advanced Therapies in Microscopic Colitis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Hereditary chronic pancreatitis induced plasticity cooperates with mutant Kras in early pancreatic carcinogenesis.

Gut·2025
Same author

Implications of Computerized Tomography Colonography in Fully Intended but Aborted Optical Colonoscopy - a Retrospective Case-Control Study.

Zeitschrift fur Gastroenterologie·2025
Same journal

Increased awareness around an ultra-rare disease can improve diagnosis delays: the French example in primary hyperoxalurias.

Orphanet journal of rare diseases·2026
Same journal

Patient-driven surveys of mucopolysaccharidoses revealed patient-reported outcomes in the Japan MPS patient and family group.

Orphanet journal of rare diseases·2026
Same journal

Mapping the landscape of treatable inborn errors of metabolism: a systematic gene-level evaluation based on the ICIMD classification.

Orphanet journal of rare diseases·2026
Same journal

Cognitive function in adult NF1 patients without other cognitive disorders: a cross-sectional study.

Orphanet journal of rare diseases·2026
Same journal

Real-world insights into neurodevelopmental outcomes amongst people with congenital hyperinsulinism.

Orphanet journal of rare diseases·2026
Same journal

Care of patients with Phenylketonuria (PKU) in Germany - a claims data analysis from 2013 to 2023.

Orphanet journal of rare diseases·2026
See all related articles

Hereditary chronic pancreatitis (HCP) is a rare, early-onset condition. While PRSS1 gene mutations are causative, other genes are associated, and management mirrors other chronic pancreatitis types.

Area of Science:

  • Gastroenterology
  • Genetics
  • Pancreatology

Background:

  • Hereditary chronic pancreatitis (HCP) is a rare, early-onset form of chronic pancreatitis.
  • Its clinical course and features resemble alcoholic chronic pancreatitis, with variable presentations including pain, digestive issues, and diabetes.
  • PRSS1 gene mutations are causative, leading to premature trypsinogen activation.

Purpose of the Study:

  • To review the characteristics, genetic basis, and management of hereditary chronic pancreatitis.
  • To highlight the association of other genes like PRSS2, SPINK1, and CFTR with chronic pancreatitis.
  • To emphasize the importance of avoiding environmental risk factors for pancreatic cancer in HCP patients.

Main Methods:

  • Review of existing literature on hereditary chronic pancreatitis.

Related Experiment Videos

  • Analysis of genetic mutations associated with chronic pancreatitis, including PRSS1, PRSS2, SPINK1, and CFTR.
  • Discussion of diagnostic criteria, treatment strategies, and prognosis.

    • Main Results:

    • PRSS1 mutations are a primary cause of HCP, increasing trypsinogen activation.
    • Other genes (PRSS2, SPINK1, CFTR) are also implicated in chronic pancreatitis.
    • HCP management involves enzyme/nutritional support, pain control, and managing complications; prognosis is unpredictable with elevated pancreatic cancer risk.

    Conclusions:

    • HCP diagnosis and treatment align with other chronic pancreatitis forms, despite genetic underpinnings.
    • Genetic testing is recommended for select patients; antenatal diagnosis is not advised.
    • Patients with HCP must avoid environmental risk factors due to increased pancreatic cancer risk.